Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
September 21, 2021
Patent Application Number
20180514
Date Filed
May 14, 2018
Patent Citations Received
Patent abstract
The invention is a composition of human insulin or insulin analog that includes specific concentrations of citrate, chloride, in some cases including the addition of sodium chloride, zinc and, optionally, magnesium chloride and/or surfactant, and that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
